RE: Endovascular Brachytherapy

["Bass, Billy G." <bgb3@mhg.edu>]

We have completed one clinical trial using the P-32 stent as well as other 
cardiovascular brachytherapy devices.  In fact, we have just completed a 
conference here in Washington, DC on Transcather Cardiovascular Therapy 
techniques which included a number of papers on different types of 
radionuclide sources.  Rather than tie up RADSAFE let me know at my e-mail 
address what types of information you need and I'll be happy to assist you 
as best as I can.  With the P-32 sources, most of which are in the sub 
microcurie range, safety is not much of a problem.  Just regulatory 
compliance and working out the qualifications of the attending medical 
professional (cardiologist, oncologist, etc.)

Bill Bass, RSO
Washington Hospital Center
Washington, DC  20010
(202) 877-8025
BGB3@MHG.EDU
 ----------
From: radsafe%romulus.ehs.uiuc.edu
To: Multiple recipients of list
Subject: Endovascular Brachytherapy
Date: Friday, September 26, 1997 5:38PM

Dear Colleagues,

Our cardiac cath laboratory  is gearing up to perform this new type of
brachytherapy with P-32 in the near future.  Does anyone have any
knowledge of available literature that may discuss or explore the safety
considerations and potential exposures received by the medical staff?
Thank you in advance.

David Engelbretson
Asst. RSO
Methodist Hospital, Houston, TX